Skip to content

Measuring Normal and Impaired Walking in Children Using the GAITRite Walkway

Measuring Normal and Impaired Walking in Children Using the GAITRite Walkway

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05571501
Enrollment
702
Registered
2022-10-07
Start date
2012-05-31
Completion date
2015-10-31
Last updated
2022-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatric Neurological, Paediatric Orthopaedic, Talipes Equino Varus, Typically Developing Children

Brief summary

Walking measurement in children is important but there are challenges associated with obtaining reliable repeatable data in a clinical setting that is meaningful and easy to interpret. This study set out to develop a new way to collect, record, and interpret walking data that is suitable for the clinical environment. Developmental percentile charts were selected as they are widely recognised and easily interpreted.

Detailed description

The primary output of the main cohort of typically developing children is the developmental percentile charts. These will be then used to present the clinical longitudinal data against a normal backdrop of developmental changes in children. This has multiple clinical applications in many of the children assessed by physiotherapy at GOSH and more widely Nationally and internationally

Interventions

DEVICEGait assessment using the GAITRIte walkway

10-20 walking assessment using the GAITRite walkway

Sponsors

GOSHCC
CollaboratorUNKNOWN
Great Ormond Street Hospital for Children NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

All children recruited underwent the GAITRite assessment

Intervention model description

The tool used for this study has been and was used for routine patient care, but was a novel diagnostic assessment for the typically developing (norms) and some of the clinical groups included. The clinical groups were compared to norms, both had the same diagnostic assessment so there was no control group who did not have the assessment

Eligibility

Sex/Gender
ALL
Age
10 Months to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Able to walk 100m

Exclusion criteria

* recent fracture or musculoskeletal injury which would affect gait

Design outcomes

Primary

MeasureTime frameDescription
Gait data recorded via GAITRite softwareFor the duration of the study measured once for typically developing and at multiple clinic visits over 24 months for clinical groupsContinuous numeric data summarising walking performance and characteristics

Secondary

MeasureTime frameDescription
demographic and clinical outcome data30 to 60 mins to collect relevant data at a single time point, with an update to include additional admissions over 24monthssurgical history (where relevant)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026